New York Governor Kathy Hochul has enacted legislation that protects employees in the state from retaliatory actions for reporting illegal or dangerous business activities. In meaningfully amending the prior law, there are multiple important and noteworthy aspects of the new law that together give crucial support to whistleblowers.
After eight years of delays, the federal and state governments have intervened in the concealed overpayments lawsuit against two Nashville-based hospice care providers and their parent company. The suit alleges that Nashville-based Avalon Hospice, Brentwood-based Regency Health Care Group and Curo Health Services, along with its parent, pressured staff to “conceal overpayments to maximize census
Lawsuit alleged AbbVie pharmaceutical company committed fraud in promotion of blockbuster prescription drug Humira The California Department of Insurance has announced a settlement agreement with AbbVie Inc. to resolve a lawsuit alleging the pharmaceutical giant violated the California Insurance Frauds Prevention Act (Act) by providing kickbacks to healthcare providers throughout California relating to the sale of its
As reported by Law.com (subscription), the U.S. Securities and Exchange Commission has given a $450,000 whistleblower award to a worker who had compliance-related job functions at an undisclosed company. This is the third time in eight years that an award has gone to an individual with compliance or internal audit duties at a company found
As reported by USA Today, there is a growing concern across the U.S. over the apparent surge in dangerous and highly expensive medications being pushed on the public by drug manufactures whose main concern is not turning a new corner in patient health but rather turning over millions in profits.
On September 18, 2018, Lieff Cabraser and California Insurance Commissioner Dave Jones sued AbbVie, Inc. for violations of the Insurance Frauds Prevention Act (“IFPA”) by providing kickbacks to healthcare providers throughout California relating to sale of the immunosuppressive drug Humira. Defendant AbbVie removed the case to federal court, arguing that the State of California should
Joint Complaint Filed Under the California Insurance Frauds Prevention Act On September 18, 2018, Lieff Cabraser and California Insurance Commissioner Dave Jones sued AbbVie, Inc. for violations of the Insurance Frauds Prevention Act (“IFPA”) by providing kickbacks to healthcare providers throughout California relating to sale of the immunosuppressive drug Humira. Humira, used to treat arthritis,